Literature DB >> 3945893

Surgical treatment of hilar carcinoma of the bile duct.

R Mizumoto, Y Kawarada, H Suzuki.   

Abstract

The operative results of hilar carcinoma of the bile duct are extremely poor and there are few long term survivors. During the past seven years and six months at our clinic, 26 of 32 patients with hilar carcinoma were operated upon and 24 of these patients underwent resection with a resectability rate of 92.3 per cent. There was one operative death and the mortality was 3.8 per cent in 26 patients operated upon and 4.2 per cent in 24 patients who underwent resection. Seven are still alive postoperatively. The longest survival time is five years and seven months without a recurrence after right trisegmentectomy for carcinoma of the intrahepatic bile duct with hilar invasion. Curative resection was performed upon ten of 26 patients who underwent operation. Of the patients who were operated upon, 12 had invasion of the parenchyma of the liver at the hilum and 11, invasion of the caudate lobe, including direct invasion in three and invasion of the bile ducts in eight. Therefore, the caudate lobe should be resected for radical operation for hilar carcinoma. In this study, the anatomy of the hilar area, including vascular structures of the caudate lobe, was evaluated in 106 cadavers, concerning radical operation for hilar carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3945893

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  48 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

3.  Major liver resection for hilar cholangiocarcinoma.

Authors:  S Bengmark; H Ekberg; A Evander; B Klofver-Stahl; K G Tranberg
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

4.  Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Authors:  Noriaki Sagawa; Satoshi Kondo; Toshiaki Morikawa; Shunichi Okushiba; Hiroyuki Katoh
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

5.  Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Authors:  J C Flickinger; A H Epstein; S Iwatsuki; B I Carr; T E Starzl
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

6.  Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience.

Authors:  Masaki Gibo; Shinobu Unten; Akira Yogi; Tadashi Nakayama; Yuichirou Ayukawa; Shinji Gibo; Sadayuki Murayama; Makoto Takara; Masayuki Shiraishi
Journal:  Radiat Med       Date:  2007-05-28

7.  Operative considerations in resection of hilar cholangiocarcinoma.

Authors:  Alexander A Parikh; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

Review 8.  Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Authors:  Saleh Abbas; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-08       Impact factor: 3.647

9.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

10.  Resection of hilar cholangiocarcinomas: pivotal prognostic factors and impact of tumor sclerosis.

Authors:  Harald Puhalla; Thomas Gruenberger; Herwig Pokorny; Thomas Soliman; Fritz Wrba; Ulrike Sponer; Thomas Winkler; Meinhard Ploner; Markus Raderer; Rudolf Steininger; Ferdinand Mühlbacher; Friedrich Laengle
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.